| WKY/NHsd |
plasma insulin level |
fasting (for 16 hours) then glucose solution (2 g/kg) |
Solberg Woods LC, et al., Mamm Genome. 2009 Aug 22 |
blood insulin amount |
female |
119.0 days
| 10 |
20.0 |
mU/l |
2.5 |
7.91 |
intraperitoneal glucose tolerance test |
0 |
post glucose injection |
60 |
min |
|
|
11614 |
107 |
| WKY/NHsd |
serum thyroid stimulating hormone level |
control condition |
Baum AE, et al., Endocrinology 2004 Oct 28;. |
blood thyroid-stimulating hormone amount |
female |
70.0 days- days |
15 |
3.0 |
ng/ml |
0.05 |
0.21 |
radioimmunoassay |
0.0 |
|
|
|
|
serum tsh |
67898 |
252 |
| WKY/NHsd |
number of rearing movements in a defensive burying apparatus |
control condition |
Baum AE, et al., Behav Brain Res. 2006 Feb 17;. |
fear-related behavior trait |
female |
77.0 days-88.0 days |
16 |
33.8 |
null |
2.65 |
10.6 |
visual assessment of in vivo video recording |
600.0 |
|
|
|
defensive burying apparatus |
number of rearing movements in a defensive burying apparatus (CMO:0004096) |
68652 |
972 |
| WKY/NHsd |
number of lines crossed in the seven-section, 50 cm diameter center of a circular open field apparatus |
control condition |
Baum AE, et al., Behav Brain Res. 2006 Feb 17;. |
anxiety-related behavior trait |
female |
77.0 days-88.0 days |
22 |
6.2 |
null |
1.43 |
6.7 |
visual assessment of in vivo video recording |
600.0 |
|
|
|
|
number of lines crossed in the seven-section, 50 cm diameter center of a circular open field apparatus (CMO:0004098) |
75706 |
972 |
| WKY/NHsd |
number of rearing movements in an open field apparatus |
control condition |
Baum AE, et al., Behav Brain Res. 2006 Feb 17;. |
exploratory behavior trait |
male |
77.0 days-88.0 days |
28 |
9.6 |
null |
1.38 |
7.3 |
visual assessment of in vivo video recording |
600.0 |
|
|
|
|
in 10min |
75698 |
972 |
| WKY/NHsd |
number of rearing movements in an open field apparatus |
control condition |
Baum AE, et al., Behav Brain Res. 2006 Feb 17;. |
exploratory behavior trait |
female |
77.0 days-88.0 days |
22 |
20.5 |
null |
2.26 |
10.6 |
visual assessment of in vivo video recording |
600.0 |
|
|
|
|
in 10min |
75692 |
972 |
| WKY/NHsd |
total accumulated grooming time in an open field apparatus |
control condition |
Baum AE, et al., Behav Brain Res. 2006 Feb 17;. |
anxiety-related behavior trait |
female |
77.0 days-88.0 days |
22 |
42.5 |
s |
6.12 |
28.7 |
visual assessment of in vivo video recording |
600.0 |
|
|
|
|
in 10min |
75696 |
972 |
| WKY/NHsd |
skin chloride level to skin water level ratio |
standard rat chow (for 8 days) then vehicle control condition (0.5 ml) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
skin chloride amount |
male |
days
| 7 |
42.0 |
mmol/l |
2.4 |
6.35 |
ex vivo analysis of atomic composition following dry ashing |
0.0 |
|
|
|
ashed skin |
skin cl/h2o |
99151 |
2238 |
| WKY/NHsd |
skin chloride level to skin water level ratio |
controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then vehicle control condition (0.5 ml) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
skin chloride amount |
male |
days
| 7 |
101.0 |
mmol/l |
3.9 |
10.32 |
ex vivo analysis of atomic composition following dry ashing |
0.0 |
|
|
|
ashed skin |
skin na/h2o |
99149 |
2238 |
| WKY/NHsd |
skin chloride level to skin water level ratio |
controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then vehicle control condition (0.5 ml) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
skin chloride amount |
male |
days
| 7 |
48.0 |
mmol/l |
4.8 |
12.7 |
ex vivo analysis of atomic composition following dry ashing |
0.0 |
|
|
|
ashed skin |
skin cl/h2o |
99153 |
2238 |
| WKY/NHsd |
skin potassium level to skin water level ratio |
controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then vehicle control condition (0.5 ml) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
skin potassium amount |
male |
days
| 7 |
71.0 |
mmol/l |
3.0 |
7.94 |
ex vivo analysis of atomic composition following dry ashing |
0.0 |
|
|
|
ashed skin |
skin k/h2o |
99157 |
2238 |
| WKY/NHsd |
plasma creatinine level |
controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
blood creatinine amount |
male |
days
| 8 |
0.32 |
mg/dl |
0.01 |
0.03 |
plasma creatinine analysis |
0.0 |
|
|
|
|
|
99174 |
2238 |
| WKY/NHsd |
skin sodium level to skin dry weight ratio |
standard rat chow (for 8 days) then vehicle control condition (0.5 ml) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
skin sodium amount |
male |
days
| 7 |
0.11 |
REQUEST NEW VALUE |
0.0 |
0.01 |
ex vivo analysis of atomic composition following dry ashing |
0.0 |
|
|
|
ashed skin |
mmol/g |
99131 |
2238 |
| WKY/NHsd |
urine sodium excretion rate |
standard rat chow (for 8 days) then vehicle control condition (0.5 ml) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
urine sodium amount |
male |
days
| 7 |
1.0 |
mEq/d |
0.2 |
0.53 |
urine sodium analysis |
0.0 |
|
|
|
|
mmol/d |
99183 |
2238 |
| WKY/NHsd |
skin sodium level to skin dry weight ratio |
controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then vehicle control condition (0.5 ml) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
skin sodium amount |
male |
days
| 7 |
0.14 |
REQUEST NEW VALUE |
0.01 |
0.01 |
ex vivo analysis of atomic composition following dry ashing |
0.0 |
|
|
|
ashed skin |
mmol/g |
99133 |
2238 |
| WKY/NHsd |
urine sodium excretion rate |
controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then vehicle control condition (0.5 ml) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
urine sodium amount |
male |
days
| 7 |
41.9 |
mEq/d |
5.2 |
13.76 |
urine sodium analysis |
0.0 |
|
|
|
|
|
99185 |
2238 |
| WKY/NHsd |
mean arterial blood pressure |
standard rat chow (for 8 days) then vehicle control condition (0.5 ml) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
arterial blood pressure trait |
male |
days
| 7 |
101.0 |
mmHg |
0.9 |
2.38 |
intra-aortic radiotelemetry |
0.0 |
|
|
|
|
|
99187 |
2238 |
| WKY/NHsd |
mean arterial blood pressure |
controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
arterial blood pressure trait |
male |
days
| 8 |
124.0 |
mmHg |
4.0 |
11.31 |
intra-aortic radiotelemetry |
0.0 |
|
|
|
|
|
99190 |
2238 |
| WKY/NHsd |
creatinine clearance |
controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then vehicle control condition (0.5 ml) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
glomerular filtration trait |
male |
days
| 7 |
3.5 |
ml/min |
0.3 |
0.79 |
urine creatinine analysis |
0.0 |
|
|
|
|
|
99181 |
2238 |
| WKY/NHsd |
artery neointimal hyperplastic lesion area to total wall area ratio |
balloon angioplasty |
Assadnia S, etal., Circ Res. 1999 Jun 11;84(11):1252-7. doi: 10.1161/01.res.84.11.1252. |
iliac artery integrity trait |
male |
119.0 days-133.0 days |
9 |
27.5 |
% |
3.5 |
10.5 |
ex vivo light microscopy with digital image analysis |
0.0 |
|
|
|
|
|
110481 |
3107 |
| WKY/NHsd |
body weight |
control condition |
Keele GR, etal., Obesity (Silver Spring). 2018 Jan;26(1):213-222. doi: 10.1002/oby.22075. Epub 2017 Nov 28. |
body mass |
male |
119.0 days
| 16 |
318.69 |
g |
9.83 |
39.31 |
body weighing method |
|
|
|
|
|
|
138413 |
3200 |
| WKY/NHsd |
epididymal fat pad weight |
control condition |
Keele GR, etal., Obesity (Silver Spring). 2018 Jan;26(1):213-222. doi: 10.1002/oby.22075. Epub 2017 Nov 28. |
epididymal fat pad mass |
male |
119.0 days
| 16 |
4.55 |
g |
0.27 |
1.07 |
post excision weight measurement |
|
|
|
|
|
|
138417 |
3200 |
| WKY/NHsd |
plasma corticosterone level |
control condition |
Solberg LC, et al., Physiol Genomics. 2006 Nov 27;27(3):362-9. Epub 2006 Aug 8 |
blood corticosterone amount |
male |
105.0 days
| 24 |
31.7 |
ng/ml |
4.2 |
20.58 |
radioimmunoassay |
|
|
|
|
|
ng/ml |
13118 |
105 |
| WKY/NHsd |
plasma glucose level |
fasting (for 16 hours) then glucose solution (2 g/kg) |
Solberg Woods LC, et al., Mamm Genome. 2009 Aug 22 |
blood glucose amount |
male |
119.0 days
| 10 |
173.8 |
mg/dl |
5.5 |
17.39 |
intraperitoneal glucose tolerance test |
0 |
post glucose injection |
60 |
min |
|
|
13173 |
107 |
| WKY/NHsd |
serum thyroid stimulating hormone level |
control condition |
Baum AE, et al., Endocrinology 2004 Oct 28;. |
blood thyroid-stimulating hormone amount |
male |
70.0 days- days |
16 |
5.28 |
ng/ml |
0.29 |
1.16 |
radioimmunoassay |
0.0 |
|
|
|
|
serum tsh |
67897 |
252 |
| WKY/NHsd |
total accumulated grooming time in a defensive burying apparatus |
control condition |
Baum AE, et al., Behav Brain Res. 2006 Feb 17;. |
anxiety-related behavior trait |
female |
77.0 days-88.0 days |
16 |
97.9 |
s |
17.75 |
71.0 |
visual assessment of in vivo video recording |
600.0 |
|
|
|
defensive burying apparatus |
total accumulated grooming time in a defensive burying apparatus (CMO:0004097) |
75700 |
972 |
| WKY/NHsd |
skin chloride level to skin dry weight ratio |
standard rat chow (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
skin chloride amount |
male |
days
| 8 |
0.05 |
mmol/g |
0.0 |
0.01 |
ex vivo analysis of atomic composition following dry ashing |
0.0 |
|
|
|
ashed skin |
skin cl mmol/g |
99136 |
2238 |
| WKY/NHsd |
skin chloride level to skin water level ratio |
standard rat chow (for 8 days) then vehicle control condition (0.5 ml) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
skin chloride amount |
male |
days
| 7 |
90.0 |
mmol/l |
0.8 |
2.12 |
ex vivo analysis of atomic composition following dry ashing |
0.0 |
|
|
|
ashed skin |
skin na/h2o |
99147 |
2238 |
| WKY/NHsd |
skin potassium level plus skin sodium level to skin water level ratio |
controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
skin mineral amount |
male |
days
| 8 |
0.17 |
null |
0.0 |
0.01 |
ex vivo analysis of atomic composition following dry ashing |
0.0 |
|
|
|
ashed skin |
skin na+k/h2o |
99146 |
2238 |
| WKY/NHsd |
skin chloride level to skin water level ratio |
controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
skin chloride amount |
male |
days
| 8 |
108.0 |
mmol/l |
4.4 |
12.45 |
ex vivo analysis of atomic composition following dry ashing |
0.0 |
|
|
|
ashed skin |
skin na/h2o |
99150 |
2238 |
| WKY/NHsd |
skin potassium level to skin water level ratio |
standard rat chow (for 8 days) then vehicle control condition (0.5 ml) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
skin potassium amount |
male |
days
| 7 |
80.0 |
mmol/l |
1.1 |
2.91 |
ex vivo analysis of atomic composition following dry ashing |
0.0 |
|
|
|
ashed skin |
skin k/h2o |
99155 |
2238 |
| WKY/NHsd |
skin potassium level to skin water level ratio |
standard rat chow (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
skin potassium amount |
male |
days
| 8 |
75.0 |
mmol/l |
1.8 |
5.09 |
ex vivo analysis of atomic composition following dry ashing |
0.0 |
|
|
|
ashed skin |
skin k/h2o |
99156 |
2238 |
| WKY/NHsd |
plasma potassium level |
standard rat chow (for 8 days) then vehicle control condition (0.5 ml) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
blood potassium amount |
male |
days
| 7 |
3.9 |
mmol/l |
0.2 |
0.53 |
automated blood electrolyte analysis |
0.0 |
|
|
|
|
|
99163 |
2238 |
| WKY/NHsd |
plasma potassium level |
standard rat chow (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
blood potassium amount |
male |
days
| 8 |
4.2 |
mmol/l |
0.3 |
0.85 |
automated blood electrolyte analysis |
0.0 |
|
|
|
|
|
99164 |
2238 |
| WKY/NHsd |
plasma creatinine level |
controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then vehicle control condition (0.5 ml) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
blood creatinine amount |
male |
days
| 7 |
0.3 |
mg/dl |
0.01 |
0.02 |
plasma creatinine analysis |
0.0 |
|
|
|
|
|
99173 |
2238 |
| WKY/NHsd |
plasma cystatin C level |
standard rat chow (for 8 days) then vehicle control condition (0.5 ml) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
blood cystatin C amount |
male |
days
| 7 |
4.0 |
mg/l |
0.6 |
1.59 |
automated plasma protein analysis |
0.0 |
|
|
|
|
|
99175 |
2238 |
| WKY/NHsd |
both adrenal glands wet weight |
control condition |
Solberg LC, et al., Physiol Genomics. 2006 Nov 27;27(3):362-9. Epub 2006 Aug 8 |
adrenal gland mass |
female |
112.0 days
| 20 |
65.8 |
mg |
1.8 |
8.05 |
post excision weight measurement |
|
|
|
|
|
|
11602 |
105 |
| WKY/NHsd |
body weight |
fasting (for 16 hours) |
Solberg Woods LC, et al., Mamm Genome. 2009 Aug 22 |
body mass |
male |
119.0 days
| 10 |
352.0 |
g |
4.5 |
14.23 |
body weighing method |
0 |
|
|
|
|
|
11608 |
107 |
| WKY/NHsd |
mammary tumor number |
7,12-dimethyltetraphene (65 mg/kg) |
Lan H, et al., Genetics 2001 Jan;157(1):331-9 |
mammary gland integrity trait |
female |
169.0 days-174.0 days |
17 |
0.0 |
null |
|
|
necropsy |
|
|
|
|
|
3X3 mm diameter or larger |
11741 |
141 |
| WKY/NHsd |
plasma corticosterone level |
physical restraint (for 0.2 hours) |
Solberg LC, et al., Physiol Genomics. 2006 Nov 27;27(3):362-9. Epub 2006 Aug 8 |
blood corticosterone amount |
male |
105.0 days
| 24 |
287.5 |
ng/ml |
21.0 |
102.88 |
radioimmunoassay |
0 |
|
|
|
|
ng/ml |
13124 |
105 |
| WKY/NHsd |
plasma glucose level |
fasting (for 16 hours) then glucose solution (2 g/kg) |
Solberg Woods LC, et al., Mamm Genome. 2009 Aug 22 |
blood glucose amount |
male |
119.0 days
| 10 |
98.1 |
mg/dl |
2.5 |
7.91 |
plasma glucose analysis |
0 |
|
|
|
|
|
13174 |
107 |
| WKY/NHsd |
plasma glucose level |
physical restraint in tube type rodent restrainer (for 0.5 hours) |
Solberg Woods LC, et al., Mamm Genome. 2009 Aug 22 |
blood glucose amount |
male |
105.0 days
| 10 |
153.5 |
mg/dl |
6.3 |
19.92 |
plasma glucose analysis |
0 |
|
|
|
|
|
13175 |
107 |
| WKY/NHsd |
plasma glucose level |
fasting (for 16 hours) then glucose solution (2 g/kg) |
Solberg Woods LC, et al., Mamm Genome. 2009 Aug 22 |
blood glucose amount |
female |
119.0 days
| 10 |
84.3 |
mg/dl |
6.9 |
21.82 |
plasma glucose analysis |
0 |
|
|
|
|
|
13184 |
107 |
| WKY/NHsd |
skin water level to skin dry weight ratio |
standard rat chow (for 8 days) then sunitinib (0.5 ml) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
skin water amount |
male |
days
| 7 |
1.22 |
ml/g |
0.03 |
0.08 |
ex vivo analysis of atomic composition following dry ashing |
0.0 |
|
|
|
ashed skin |
skin h2o ml/g |
99139 |
2238 |
| WKY/NHsd |
skin potassium level plus skin sodium level to skin water level ratio |
standard rat chow (for 8 days) then vehicle control condition (0.5 ml) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
skin mineral amount |
male |
days
| 7 |
0.17 |
null |
0.0 |
0.0 |
ex vivo analysis of atomic composition following dry ashing |
0.0 |
|
|
|
ashed skin |
skin na+k/h2o |
99143 |
2238 |
| WKY/NHsd |
skin water level to skin dry weight ratio |
controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
skin water amount |
male |
days
| 8 |
1.52 |
ml/g |
0.0 |
0.01 |
ex vivo analysis of atomic composition following dry ashing |
0.0 |
|
|
|
ashed skin |
skin h2o ml/g |
99142 |
2238 |
| WKY/NHsd |
plasma sodium level |
standard rat chow (for 8 days) then vehicle control condition (0.5 ml) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
blood sodium amount |
male |
days
| 7 |
143.7 |
mmol/l |
4.4 |
11.64 |
automated blood electrolyte analysis |
0.0 |
|
|
|
|
|
99159 |
2238 |
| WKY/NHsd |
plasma sodium level |
standard rat chow (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
blood sodium amount |
male |
days
| 8 |
137.8 |
mmol/l |
2.3 |
6.51 |
automated blood electrolyte analysis |
0.0 |
|
|
|
|
|
99160 |
2238 |
| WKY/NHsd |
plasma potassium level |
controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
blood potassium amount |
male |
days
| 8 |
4.4 |
mmol/l |
0.4 |
1.13 |
automated blood electrolyte analysis |
0.0 |
|
|
|
|
|
99166 |
2238 |
| WKY/NHsd |
plasma chloride level |
standard rat chow (for 8 days) then vehicle control condition (0.5 ml) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
blood chloride amount |
male |
days
| 7 |
98.2 |
mmol/l |
1.1 |
2.91 |
automated blood electrolyte analysis |
0.0 |
|
|
|
|
|
99167 |
2238 |
| WKY/NHsd |
plasma cystatin C level |
controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then vehicle control condition (0.5 ml) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
blood cystatin C amount |
male |
days
| 7 |
3.5 |
mg/l |
0.2 |
0.53 |
automated plasma protein analysis |
0.0 |
|
|
|
|
|
99177 |
2238 |
| WKY/NHsd |
plasma cystatin C level |
standard rat chow (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
blood cystatin C amount |
male |
days
| 8 |
4.7 |
mg/l |
0.3 |
0.85 |
automated plasma protein analysis |
0.0 |
|
|
|
|
plasma cystatin c |
99176 |
2238 |
| WKY/NHsd |
skin sodium level to skin dry weight ratio |
controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
skin sodium amount |
male |
days
| 8 |
0.16 |
REQUEST NEW VALUE |
0.01 |
0.03 |
ex vivo analysis of atomic composition following dry ashing |
0.0 |
|
|
|
ashed skin |
mmol/g |
99134 |
2238 |
| WKY/NHsd |
urine sodium excretion rate |
standard rat chow (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
urine sodium amount |
male |
days
| 8 |
1.1 |
mEq/d |
0.1 |
0.28 |
urine sodium analysis |
0.0 |
|
|
|
|
|
99184 |
2238 |
| WKY/NHsd |
mean arterial blood pressure |
controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then vehicle control condition (0.5 ml) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
arterial blood pressure trait |
male |
days
| 7 |
116.0 |
mmHg |
1.0 |
2.65 |
intra-aortic radiotelemetry |
0.0 |
|
|
|
|
|
99189 |
2238 |
| WKY/NHsd |
creatinine clearance |
standard rat chow (for 8 days) then vehicle control condition (0.5 ml) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
glomerular filtration trait |
male |
days
| 7 |
3.1 |
ml/min |
0.5 |
1.32 |
urine creatinine analysis |
0.0 |
|
|
|
|
|
99179 |
2238 |
| WKY/NHsd |
creatinine clearance |
controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
glomerular filtration trait |
male |
days
| 8 |
3.5 |
ml/min |
0.2 |
0.57 |
urine creatinine analysis |
0.0 |
|
|
|
|
|
99182 |
2238 |
| WKY/NHsd |
artery neointimal hyperplastic lesion area |
balloon angioplasty |
Assadnia S, etal., Circ Res. 1999 Jun 11;84(11):1252-7. doi: 10.1161/01.res.84.11.1252. |
iliac artery integrity trait |
male |
119.0 days-133.0 days |
9 |
0.04 |
mm2 |
0.01 |
0.02 |
ex vivo light microscopy with digital image analysis |
0.0 |
|
|
|
|
|
110470 |
3107 |
| WKY/NHsd |
body weight |
fasting (for 16 hours) |
Solberg Woods LC, et al., Mamm Genome. 2009 Aug 22 |
body mass |
female |
119.0 days
| 10 |
230.0 |
g |
3.2 |
10.12 |
body weighing method |
0 |
|
|
|
|
|
11610 |
107 |
| WKY/NHsd |
total accumulated grooming time in an open field apparatus |
control condition |
Baum AE, et al., Behav Brain Res. 2006 Feb 17;. |
anxiety-related behavior trait |
male |
77.0 days-88.0 days |
28 |
35.3 |
s |
7.48 |
39.6 |
visual assessment of in vivo video recording |
600.0 |
|
|
|
|
in 10min |
68654 |
972 |
| WKY/NHsd |
number of rearing movements in a defensive burying apparatus |
control condition |
Baum AE, et al., Behav Brain Res. 2006 Feb 17;. |
fear-related behavior trait |
male |
77.0 days-88.0 days |
26 |
17.8 |
null |
1.45 |
7.4 |
visual assessment of in vivo video recording |
600.0 |
|
|
|
defensive burying apparatus |
number of rearing movements in a defensive burying apparatus (CMO:0004096) |
75694 |
972 |
| WKY/NHsd |
skin chloride level to skin dry weight ratio |
standard rat chow (for 8 days) then vehicle control condition (0.5 ml) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
skin chloride amount |
male |
days
| 7 |
0.05 |
mmol/g |
0.0 |
0.01 |
ex vivo analysis of atomic composition following dry ashing |
0.0 |
|
|
|
ashed skin |
skin cl mmol/g |
99135 |
2238 |
| WKY/NHsd |
skin water level to skin dry weight ratio |
standard rat chow (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
skin water amount |
male |
days
| 8 |
1.21 |
ml/g |
0.02 |
0.05 |
ex vivo analysis of atomic composition following dry ashing |
0.0 |
|
|
|
ashed skin |
skin h2o ml/g |
99140 |
2238 |
| WKY/NHsd |
skin chloride level to skin dry weight ratio |
controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
skin chloride amount |
male |
days
| 8 |
0.07 |
mmol/g |
0.01 |
0.02 |
ex vivo analysis of atomic composition following dry ashing |
0.0 |
|
|
|
ashed skin |
skin cl mmol/g |
99138 |
2238 |
| WKY/NHsd |
skin water level to skin dry weight ratio |
controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then vehicle control condition (0.5 ml) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
skin water amount |
male |
days
| 7 |
1.43 |
ml/g |
0.03 |
0.08 |
ex vivo analysis of atomic composition following dry ashing |
0.0 |
|
|
|
ashed skin |
skin h2o ml/g |
99141 |
2238 |
| WKY/NHsd |
skin potassium level plus skin sodium level to skin water level ratio |
standard rat chow (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
skin mineral amount |
male |
days
| 8 |
0.17 |
null |
0.0 |
0.01 |
ex vivo analysis of atomic composition following dry ashing |
0.0 |
|
|
|
ashed skin |
skin na+k/h2o |
99144 |
2238 |
| WKY/NHsd |
skin potassium level plus skin sodium level to skin water level ratio |
controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then vehicle control condition (0.5 ml) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
skin mineral amount |
male |
days
| 7 |
0.18 |
null |
0.01 |
0.02 |
ex vivo analysis of atomic composition following dry ashing |
0.0 |
|
|
|
ashed skin |
skin na+k/h2o |
99145 |
2238 |
| WKY/NHsd |
skin chloride level to skin water level ratio |
standard rat chow (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
skin chloride amount |
male |
days
| 8 |
92.0 |
mmol/l |
1.5 |
4.24 |
ex vivo analysis of atomic composition following dry ashing |
0.0 |
|
|
|
ashed skin |
skin na/h2o |
99148 |
2238 |
| WKY/NHsd |
skin chloride level to skin water level ratio |
controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
skin chloride amount |
male |
days
| 8 |
50.0 |
mmol/l |
4.4 |
12.45 |
ex vivo analysis of atomic composition following dry ashing |
0.0 |
|
|
|
ashed skin |
skin cl/h2o |
99154 |
2238 |
| WKY/NHsd |
plasma chloride level |
standard rat chow (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
blood chloride amount |
male |
days
| 8 |
100.5 |
mmol/l |
0.5 |
1.41 |
automated blood electrolyte analysis |
0.0 |
|
|
|
|
|
99168 |
2238 |
| WKY/NHsd |
plasma creatinine level |
standard rat chow (for 8 days) then vehicle control condition (0.5 ml) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
blood creatinine amount |
male |
days
| 7 |
0.31 |
mg/dl |
0.01 |
0.03 |
plasma creatinine analysis |
0.0 |
|
|
|
|
|
99171 |
2238 |
| WKY/NHsd |
plasma chloride level |
controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
blood chloride amount |
male |
days
| 8 |
109.1 |
mmol/l |
1.0 |
2.83 |
automated blood electrolyte analysis |
0.0 |
|
|
|
|
|
99170 |
2238 |
| WKY/NHsd |
plasma creatinine level |
standard rat chow (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
blood creatinine amount |
male |
days
| 8 |
0.35 |
mg/dl |
0.02 |
0.05 |
plasma creatinine analysis |
0.0 |
|
|
|
|
|
99172 |
2238 |
| WKY/NHsd |
skin sodium level to skin dry weight ratio |
standard rat chow (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
skin sodium amount |
male |
days
| 8 |
0.11 |
REQUEST NEW VALUE |
0.0 |
0.01 |
ex vivo analysis of atomic composition following dry ashing |
0.0 |
|
|
|
ashed skin |
mmol/g |
99132 |
2238 |
| WKY/NHsd |
plasma chloride level |
controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then vehicle control condition (0.5 ml) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
blood chloride amount |
male |
days
| 7 |
104.8 |
mmol/l |
1.8 |
4.76 |
automated blood electrolyte analysis |
0.0 |
|
|
|
|
|
99169 |
2238 |
| WKY/NHsd |
creatinine clearance |
standard rat chow (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
glomerular filtration trait |
male |
days
| 8 |
3.1 |
ml/min |
0.5 |
1.41 |
urine creatinine analysis |
0.0 |
|
|
|
|
|
99180 |
2238 |
| WKY/NHsd |
nose to tail body mass index |
control condition |
Keele GR, etal., Obesity (Silver Spring). 2018 Jan;26(1):213-222. doi: 10.1002/oby.22075. Epub 2017 Nov 28. |
body mass |
male |
119.0 days
| 16 |
2.27 |
(g/cm2) x 10 |
0.04 |
0.15 |
body weighing method |
|
|
|
|
|
|
138415 |
3200 |
| WKY/NHsd |
nose to rump body mass index |
control condition |
Keele GR, etal., Obesity (Silver Spring). 2018 Jan;26(1):213-222. doi: 10.1002/oby.22075. Epub 2017 Nov 28. |
body mass |
male |
119.0 days
| 16 |
7.9 |
(g/cm2) x 10 |
0.2 |
0.78 |
body weighing method |
|
|
|
|
|
|
138414 |
3200 |
| WKY/NHsd |
plasma corticosterone level |
control condition |
Solberg LC, et al., Physiol Genomics. 2006 Nov 27;27(3):362-9. Epub 2006 Aug 8 |
blood corticosterone amount |
female |
105.0 days
| 20 |
113.0 |
ng/ml |
18.9 |
84.52 |
radioimmunoassay |
|
|
|
|
|
|
13121 |
105 |
| WKY/NHsd |
plasma corticosterone level |
physical restraint (for 0.2 hours) |
Solberg LC, et al., Physiol Genomics. 2006 Nov 27;27(3):362-9. Epub 2006 Aug 8 |
blood corticosterone amount |
female |
105.0 days
| 20 |
584.5 |
ng/ml |
33.5 |
149.82 |
radioimmunoassay |
0 |
|
|
|
|
|
13128 |
105 |
| WKY/NHsd |
plasma glucose level |
physical restraint in tube type rodent restrainer (for 0.5 hours) |
Solberg Woods LC, et al., Mamm Genome. 2009 Aug 22 |
blood glucose amount |
female |
105.0 days
| 10 |
151.6 |
mg/dl |
4.7 |
14.86 |
plasma glucose analysis |
0 |
|
|
|
|
|
13182 |
107 |
| WKY/NHsd |
plasma glucose level |
fasting (for 16 hours) then glucose solution (2 g/kg) |
Solberg Woods LC, et al., Mamm Genome. 2009 Aug 22 |
blood glucose amount |
female |
119.0 days
| 10 |
163.7 |
mg/dl |
7.2 |
22.77 |
intraperitoneal glucose tolerance test |
0 |
post glucose injection |
60 |
min |
|
|
13183 |
107 |
| WKY/NHsd |
both adrenal glands wet weight |
control condition |
Solberg LC, et al., Physiol Genomics. 2006 Nov 27;27(3):362-9. Epub 2006 Aug 8 |
adrenal gland mass |
male |
112.0 days
| 24 |
43.0 |
mg |
1.2 |
5.88 |
post excision weight measurement |
|
|
|
|
|
|
11600 |
105 |
| WKY/NHsd |
plasma insulin level |
fasting (for 16 hours) then glucose solution (2 g/kg) |
Solberg Woods LC, et al., Mamm Genome. 2009 Aug 22 |
blood insulin amount |
male |
119.0 days
| 10 |
64.1 |
mU/l |
9.7 |
30.67 |
intraperitoneal glucose tolerance test |
0 |
post glucose injection |
60 |
min |
|
|
11612 |
107 |
| WKY/NHsd |
number of lines crossed in the seven-section, 50 cm diameter center of a circular open field apparatus |
control condition |
Baum AE, et al., Behav Brain Res. 2006 Feb 17;. |
anxiety-related behavior trait |
male |
77.0 days-88.0 days |
28 |
4.0 |
null |
0.87 |
4.6 |
visual assessment of in vivo video recording |
600.0 |
|
|
|
|
number of lines crossed in the seven-section, 50 cm diameter center of a circular open field apparatus (CMO:0004098) |
75704 |
972 |
| WKY/NHsd |
total accumulated grooming time in a defensive burying apparatus |
control condition |
Baum AE, et al., Behav Brain Res. 2006 Feb 17;. |
anxiety-related behavior trait |
male |
77.0 days-88.0 days |
26 |
82.4 |
s |
12.34 |
62.9 |
visual assessment of in vivo video recording |
600.0 |
|
|
|
defensive burying apparatus |
total accumulated grooming time in a defensive burying apparatus (CMO:0004097) |
75702 |
972 |
| WKY/NHsd |
skin chloride level to skin dry weight ratio |
controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then vehicle control condition (0.5 ml) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
skin chloride amount |
male |
days
| 7 |
0.07 |
mmol/g |
0.01 |
0.02 |
ex vivo analysis of atomic composition following dry ashing |
0.0 |
|
|
|
ashed skin |
skin cl mmol/g |
99137 |
2238 |
| WKY/NHsd |
skin chloride level to skin water level ratio |
standard rat chow (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
skin chloride amount |
male |
days
| 8 |
43.0 |
mmol/l |
1.5 |
4.24 |
ex vivo analysis of atomic composition following dry ashing |
0.0 |
|
|
|
ashed skin |
skin cl/h2o |
99152 |
2238 |
| WKY/NHsd |
plasma sodium level |
controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then vehicle control condition (0.5 ml) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
blood sodium amount |
male |
days
| 7 |
141.4 |
mmol/l |
2.1 |
5.56 |
automated blood electrolyte analysis |
0.0 |
|
|
|
|
|
99161 |
2238 |
| WKY/NHsd |
skin potassium level to skin water level ratio |
controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
skin potassium amount |
male |
days
| 8 |
69.0 |
mmol/l |
2.5 |
7.07 |
ex vivo analysis of atomic composition following dry ashing |
0.0 |
|
|
|
ashed skin |
skin k/h2o |
99158 |
2238 |
| WKY/NHsd |
plasma sodium level |
controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
blood sodium amount |
male |
days
| 8 |
139.4 |
mmol/l |
1.7 |
4.81 |
automated blood electrolyte analysis |
0.0 |
|
|
|
|
|
99162 |
2238 |
| WKY/NHsd |
plasma potassium level |
controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then vehicle control condition (0.5 ml) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
blood potassium amount |
male |
days
| 7 |
4.2 |
mmol/l |
0.3 |
0.79 |
automated blood electrolyte analysis |
0.0 |
|
|
|
|
|
99165 |
2238 |
| WKY/NHsd |
plasma cystatin C level |
controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
blood cystatin C amount |
male |
days
| 8 |
3.9 |
mg/l |
0.3 |
0.85 |
automated plasma protein analysis |
0.0 |
|
|
|
|
|
99178 |
2238 |
| WKY/NHsd |
urine sodium excretion rate |
controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
urine sodium amount |
male |
days
| 8 |
34.3 |
mEq/d |
1.8 |
5.09 |
urine sodium analysis |
0.0 |
|
|
|
|
|
99186 |
2238 |
| WKY/NHsd |
mean arterial blood pressure |
standard rat chow (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days) |
Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. |
arterial blood pressure trait |
male |
days
| 8 |
128.0 |
mmHg |
3.0 |
8.49 |
intra-aortic radiotelemetry |
0.0 |
|
|
|
|
|
99188 |
2238 |
| WKY/NHsd |
artery neointimal hyperplastic lesion area including tunica media |
balloon angioplasty |
Assadnia S, etal., Circ Res. 1999 Jun 11;84(11):1252-7. doi: 10.1161/01.res.84.11.1252. |
iliac artery integrity trait |
male |
119.0 days-133.0 days |
9 |
0.13 |
mm2 |
0.01 |
0.04 |
ex vivo light microscopy with digital image analysis |
0.0 |
|
|
|
|
|
110459 |
3107 |
| WKY/NHsd |
retroperitoneal fat pad weight |
control condition |
Keele GR, etal., Obesity (Silver Spring). 2018 Jan;26(1):213-222. doi: 10.1002/oby.22075. Epub 2017 Nov 28. |
retroperitoneal fat pad mass |
male |
119.0 days
| 16 |
4.88 |
g |
0.66 |
2.63 |
post excision weight measurement |
|
|
|
|
|
|
138416 |
3200 |